These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38994695)

  • 21. Identification of Potential Biomarkers for Ryanodine Receptor 1 (RYR1) Mutation-Associated Myopathies Using Bioinformatics Approach.
    Wang X; Kong C; Liu P; Geng W; Tang H
    Dis Markers; 2022; 2022():8787782. PubMed ID: 35692882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful Correction by Prime Editing of a Mutation in the
    Godbout K; Rousseau J; Tremblay JP
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapies for RyR1-related myopathies.
    Marty I; Beaufils M; Fauré J; Rendu J
    Curr Opin Pharmacol; 2023 Feb; 68():102330. PubMed ID: 36529094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.
    Garibaldi M; Rendu J; Brocard J; Lacene E; Fauré J; Brochier G; Beuvin M; Labasse C; Madelaine A; Malfatti E; Bevilacqua JA; Lubieniecki F; Monges S; Taratuto AL; Laporte J; Marty I; Antonini G; Romero NB
    Acta Neuropathol Commun; 2019 Jan; 7(1):3. PubMed ID: 30611313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A drug and ATP binding site in type 1 ryanodine receptor.
    Melville Z; Dridi H; Yuan Q; Reiken S; Wronska A; Liu Y; Clarke OB; Marks AR
    Structure; 2022 Jul; 30(7):1025-1034.e4. PubMed ID: 35580609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ryanodine Receptor Calcium Leak in Circulating B-Lymphocytes as a Biomarker in Heart Failure.
    Kushnir A; Santulli G; Reiken SR; Coromilas E; Godfrey SJ; Brunjes DL; Colombo PC; Yuzefpolskaya M; Sokol SI; Kitsis RN; Marks AR
    Circulation; 2018 Sep; 138(11):1144-1154. PubMed ID: 29593014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potassium dependent rescue of a myopathy with core-like structures in mouse.
    Hanson MG; Wilde JJ; Moreno RL; Minic AD; Niswander L
    Elife; 2015 Jan; 4():. PubMed ID: 25564733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores.
    Monnier N; Marty I; Faure J; Castiglioni C; Desnuelle C; Sacconi S; Estournet B; Ferreiro A; Romero N; Laquerriere A; Lazaro L; Martin JJ; Morava E; Rossi A; Van der Kooi A; de Visser M; Verschuuren C; Lunardi J
    Hum Mutat; 2008 May; 29(5):670-8. PubMed ID: 18253926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping domains and mutations on the skeletal muscle ryanodine receptor channel.
    Hwang JH; Zorzato F; Clarke NF; Treves S
    Trends Mol Med; 2012 Nov; 18(11):644-57. PubMed ID: 23069638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors.
    Ruiz A; Benucci S; Duthaler U; Bachmann C; Franchini M; Noreen F; Pietrangelo L; Protasi F; Treves S; Zorzato F
    Elife; 2022 Mar; 11():. PubMed ID: 35238775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
    Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
    J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative proteomic analysis of skeletal muscles from wild-type and transgenic mice carrying recessive
    Eckhardt J; Ruiz A; Koenig S; Frieden M; Meier H; Schmidt A; Treves S; Zorzato F
    Elife; 2023 Mar; 12():. PubMed ID: 36862731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 182nd ENMC International Workshop: RYR1-related myopathies, 15-17th April 2011, Naarden, The Netherlands.
    Jungbluth H; Dowling JJ; Ferreiro A; Muntoni F
    Neuromuscul Disord; 2012 May; 22(5):453-62. PubMed ID: 22226685
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Løseth S; Voermans NC; Torbergsen T; Lillis S; Jonsrud C; Lindal S; Kamsteeg EJ; Lammens M; Broman M; Dekomien G; Maddison P; Muntoni F; Sewry C; Radunovic A; de Visser M; Straub V; van Engelen B; Jungbluth H
    J Neurol; 2013 Jun; 260(6):1504-10. PubMed ID: 23329375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies.
    Xu L; Wang Y; Yamaguchi N; Pasek DA; Meissner G
    J Biol Chem; 2008 Mar; 283(10):6321-9. PubMed ID: 18171678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.